Switch to:
More From Other Websites
Allergan (AGN) in Focus: Stock Jumps 6.1% - Tale of the Tape Jul 28 2015
The real reasons for the pharma merger boom Jul 28 2015
Dissecting big pharma's numbers: Pro Jul 28 2015
Hikma buys US generic drugmaker Roxane for $2.65bn Jul 28 2015
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion Jul 28 2015
Health Care & Industrials: Two ETFs Trading with Outsized Volume - ETF News And Commentary Jul 28 2015
PRESS DIGEST- New York Times business news - July 28 Jul 27 2015
Teva’s Allergan Deal Looks a Healthier Mouthful Jul 27 2015
Allergan’s Healthy Price May Come With Side Effects Jul 27 2015
Allergan sells generic drug unit to Israel's Teva for $40.5 billion Jul 27 2015
Baidu U.S. shares fall on earnings miss, revenue forecast Jul 27 2015
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's... Jul 27 2015
Business Highlights Jul 27 2015
[video]Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid Jul 27 2015
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan’s... Jul 27 2015
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
Teva buys Allergan: 3 reasons why it’s a blockbuster deal Jul 27 2015
Teva Tags Allergan's Generics: $40.5 Bil Jul 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK